Clinigen Group Plc (LON:CLIN) Weekly Ratings on Jun 27, 2018

June 27, 2018 - By Anthony Rauscher

Clinigen Group Plc (LON:CLIN) Corporate Logo

Clinigen Group Plc (LON:CLIN) Ratings Coverage

In total 4 analysts cover Clinigen Group (LON:CLIN). “Buy” rating has 4, “Sell” are 0, while 0 are “Hold”. (LON:CLIN) has 100% bullish analysts. With GBX 1350 highest and GBX 1160 lowest target, Clinigen Group has GBX 1235.75 average target or 44.53% above the current (GBX 855) price. 14 are the (LON:CLIN)’s ratings reports on Jun 27, 2018 according to StockzIntelligence Inc. In Tuesday, February 27 report Numis Securities maintained the stock with “Add” rating. On Wednesday, April 4 the firm earned “Buy” rating by Peel Hunt. On Thursday, February 1 the firm has “Buy” rating by Peel Hunt given. On Thursday, May 31 the firm earned “Buy” rating by Peel Hunt. On Wednesday, May 23 the firm earned “Buy” rating by Berenberg. On Thursday, March 1 Peel Hunt maintained Clinigen Group Plc (LON:CLIN) with “Buy” rating. On Wednesday, January 17 Peel Hunt maintained the shares of CLIN in report with “Buy” rating. The stock rating was upgraded by Numis Securities to “Buy” on Thursday, May 31. On Wednesday, January 17 N+1 Singer maintained Clinigen Group Plc (LON:CLIN) rating. N+1 Singer has “Buy” rating and GBX 1225 target. On Tuesday, February 27 Peel Hunt maintained the shares of CLIN in report with “Buy” rating. Listed here are Clinigen Group Plc (LON:CLIN) PTs and latest ratings.

31/05/2018 Broker: Numis Securities Rating: Buy Old Target: GBX 1208.00 Upgrade
31/05/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 1350.00 Maintain
23/05/2018 Broker: Berenberg Rating: Buy Old Target: GBX 1220.00 New Target: GBX 1160.00 Maintain
04/04/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 1350.00 Maintain
27/03/2018 Broker: Berenberg Rating: Buy Old Target: GBX 1220.00 New Target: GBX 1160.00 Reiteration
19/03/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 1350.00 New Target: GBX 1350.00 Maintain
01/03/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 1350.00 New Target: GBX 1350.00 Maintain
27/02/2018 Broker: Numis Securities Rating: Add Old Target: GBX 1208.00 New Target: GBX 1208.00 Maintain
27/02/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 1350.00 New Target: GBX 1350.00 Maintain
01/02/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 1350.00 New Target: GBX 1350.00 Maintain

CLIN hit GBX 855 during the last trading session after GBX 3 change.Currently Clinigen Group Plc is after 0.00% change in last June 27, 2017. CLIN has 132,305 shares volume. CLIN underperformed the S&P500 by 12.57%.

Clinigen Group plc operates as a specialty pharmaceutical and services firm in the United Kingdom, Europe, the United States, and internationally.The firm is valued at 1.05 billion GBP. The Company’s Clinigen Clinical Trial Services business supplies and manages commercial medical products, including comparator drugs, adjuvant drugs, and rescue therapies for patients in clinical trials, as well as provides value added services.The P/E ratio is 76.34. The companyÂ’s Idis Managed Access business is involved in the consultancy, development, management, and implementation of managed access programs for biotechnology and pharmaceutical companies.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.